海外の治験の状況「1」での検索結果
1495件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Empagliflozin as Adjunctive to inSulin thErapy in Type 1 diabetes over 52 weeks (EASE-2)
- Type 1 diabetes mellitus br>MedDRA version: 19.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
- Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Netherlands, Norway, Poland, Spain, Sweden, Taiwan, United Kingdom, United States
- 2015-04-02
Not Recruiting
- The efficacy and safety of liraglutide adjunct to insulin treatment in type 1 diabetes
- Diabetes Mellitus, Type 1 MedDRA version: 16.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria, Belgium, Bulgaria, Canada, Denmark, European Union, Finland, Netherlands, South Africa, Spain, Sweden, United States
- 2014-01-10
Not Recruiting
- Investigation of the effect of fibrinogen on blood clotting in patients with lack of platelets before and after a platelet-transfusion
- Thrombocytopenia MedDRA version: 14.1 Level: HLT Classification code 10043555 Term: Thrombocytopenias System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Denmark
- 2012-09-26
Recruiting
- Graz Osteoprotegerin as a Risk Factor (GORF) Study
- Prevalent OPG and RANKL Excession in Patients With CAD
- Austria
- 2012-04-04
Not Recruiting
- A 24-week, randomized, open-label, parallel group multinational comparison of Lantus® (insulin glargine) given in the morning as once-a-day basal insulin versus Neutral Protamine Hagedorn (NPH) insulin, in children with type 1 diabetes mellitus aged at least 1 year to less than 6 years - PRESCHOOL (PRESchool CHildren with type 1 diabetes On mOrning Lantus)
- Patients with type 1 diabetes mellitus, aged at least 1 year to less than 6 years MedDRA version: 12.0 Level: LLT Classification code 10012609 Term:
- Austria, Czech Republic, Hungary, Spain
- 2009-07-15
Not Recruiting
- A clinical trial to see the effect of SKI-606 in Philadelphia Chromosome Positive Leukemias
- Leukemia, Myeloid, Philadelphia Positive
- Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Finland, Germany, Hong Kong, Hungary, India, Italy, Mexico, Netherlands, Peru, Republic of Korea, Russian Federation, Singapore, South Africa, Spain, Sweden, Taiwan, United Kingdom, United States of America
- 2009-09-01
Not Recruiting
- A study to evaluate the safety, reactogenicity nad immunogenicity of the GSK investigational vaccine GSK3003891A in healthy pregnant women and infants born to vaccinated mothers
- Healthy pregnant women (Respiratory Syncytial Virus) MedDRA version: 19.1 Level: PT Classification code 10061603 Term: Respiratory syncytial virus infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Australia, Canada, Finland, Honduras, New Zealand, Panama, South Africa, Spain, United Kingdom, United States
- 2017-01-31
Authorised
- A Phase II Study of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea (HECNU) in pancreatic cancer - Phase II trial with FFC33
- Pancreatic cancer
- Austria
- 2005-07-20
Not recruiting
- A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
- Cardiovascular Disease;Cerebrovascular Accident;Coronary Heart Disease
- Australia, Austria, Belgium, Canada, France, Germany, Ireland, Italy, Netherlands, South Africa, Spain, Switzerland, United Kingdom, United States
- 2006-05-16
Not recruiting
- Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
- Hyperlipidemias;Atherosclerosis;Coronary Heart Disease;Carotid Stenosis;Peripheral Vascular Diseases;Diabetes Mellitus
- Austria
- 2007-09-27
